Screener
Denali Therapeutics Inc. DNLI Milestone Payment — Total collaboration revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The source filing: Denali Therapeutics Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:08 PM EDT
- Fiscal quarter
- Q4 FY2026
- Calendar quarter
- Q4 2026
- Accession
- 0001714899-26-000097
As of June 30, 2026, the Company had earned an aggregate of $10.0 million in option fee payments and $10.0 million in milestone payments from Takeda under the PTV:PGRN and ATV:TREM2 Collaboration Agreements, and had not recorded any product sales under either agreement.
Item 1. Financial Statements (Unaudited)
FAQ
- What is Denali Therapeutics Inc.'s milestone payment — total collaboration revenue?
- Denali Therapeutics Inc. (DNLI) reported milestone payment — total collaboration revenue of $2.5M in Q4 2026.
- How has Denali Therapeutics Inc.'s milestone payment — total collaboration revenue changed year-over-year?
- Denali Therapeutics Inc.'s milestone payment — total collaboration revenue decreased by 0.0% year-over-year, from $2.5M to $2.5M.
- What is the long-term trend for Denali Therapeutics Inc.'s milestone payment — total collaboration revenue?
- Over 2 years (2024 to 2026), Denali Therapeutics Inc.'s milestone payment — total collaboration revenue has grown at a 0.0% compound annual growth rate (CAGR), from $10M to $10M.
- What does milestone payment — total collaboration revenue mean?
- This metric represents the total revenue recognized from milestone payments received through strategic research and development collaborations. These payments are typically triggered by the achievement of specific clinical, regulatory, or commercial objectives within a partnership agreement. It serves as a key indicator of the company's ability to successfully advance its pipeline assets and validate its proprietary technology platforms through external validation.
Ask your AI about Denali Therapeutics Inc.'s milestone payment — total collaboration revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude